[
  {
    "id": "metformin",
    "name": "Metformin",
    "searchTerms": ["metformin", "glucophage"],
    "className": "Biguanide, oral hypoglycaemic",
    "tags": ["Diabetes", "eGFR-based"],
    "usualDose": "Typically 1–2 g/day in divided doses (max 2–3 g/day depending on prep).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60 mL/min/1.73 m²",
        "category": "No dose change",
        "details": "Usual dosing with annual renal monitoring and checks before contrast/surgery."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45–59 mL/min/1.73 m²",
        "category": "Caution",
        "details": "Standard doses often fine; increase monitoring frequency and avoid starting in very high-risk patients."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44 mL/min/1.73 m²",
        "category": "Dose reduction",
        "details": "Reduce total daily dose (e.g. ~50%) and monitor 3-monthly. Stop during acute illness or dehydration."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30 mL/min/1.73 m²",
        "category": "Avoid",
        "details": "Avoid metformin due to lactic acidosis risk; use alternative glucose-lowering strategy."
      }
    ],
    "notes": [
      "Stop temporarily for sepsis, dehydration, hypoxia, contrast and major surgery."
    ]
  },
  {
    "id": "gliclazide",
    "name": "Gliclazide",
    "searchTerms": ["gliclazide"],
    "className": "Sulfonylurea",
    "tags": ["Diabetes", "Hypoglycaemia risk"],
    "usualDose": "40–320 mg/day in 1–2 doses (MR usually once daily).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard dosing",
        "details": "Use usual titration; monitor for hypoglycaemia."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Caution",
        "details": "Lower starting dose and cautious titration; increased risk of prolonged hypos."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Use with care",
        "details": "Prefer alternatives; if used, very low doses with close monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Generally avoid",
        "details": "Avoid because of significant hypoglycaemia risk."
      }
    ],
    "notes": [
      "Warn about driving and hypos, especially as renal function declines."
    ]
  },
  {
    "id": "insulin-basal",
    "name": "Basal insulin (e.g. insulin glargine)",
    "searchTerms": ["insulin", "glargine", "lantus", "abasaglar"],
    "className": "Basal insulin analogue",
    "tags": ["Diabetes"],
    "usualDose": "Once or twice daily, fully individualised by glucose profile.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Adjust to glucose",
        "details": "No fixed renal table; insulin requirements usually fall as eGFR declines. Use glucose readings to titrate."
      }
    ],
    "notes": [
      "Hypoglycaemia risk rises in CKD; review total insulin dose regularly."
    ]
  },
  {
    "id": "empagliflozin",
    "name": "Empagliflozin",
    "searchTerms": ["empagliflozin", "jardiance"],
    "className": "SGLT2 inhibitor",
    "tags": ["Diabetes", "HF", "CKD"],
    "usualDose": "10–25 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard use",
        "details": "Usual doses for T2DM/HF/CKD as per SPC."
      },
      {
        "min": 20,
        "max": 60,
        "label": "eGFR 20–59",
        "category": "Indication-dependent",
        "details": "For HF/CKD, can often continue or initiate down to eGFR ~20; glucose-lowering effect reduced."
      },
      {
        "min": null,
        "max": 20,
        "label": "eGFR < 20",
        "category": "Check SPC",
        "details": "Often avoid initiating; continuing therapy requires specialist/label-based decision."
      }
    ],
    "notes": [
      "Follow SPC and local HF/CKD guidance for exact eGFR cut-offs."
    ]
  },
  {
    "id": "dapagliflozin",
    "name": "Dapagliflozin",
    "searchTerms": ["dapagliflozin", "forxiga"],
    "className": "SGLT2 inhibitor",
    "tags": ["Diabetes", "HF", "CKD"],
    "usualDose": "10 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard use",
        "details": "Use per SPC for T2DM/HF/CKD."
      },
      {
        "min": 15,
        "max": 60,
        "label": "eGFR 15–59",
        "category": "Indication-dependent",
        "details": "For HF/CKD indications can often be used down to eGFR ~15; minimal glycaemic effect at lower eGFR."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Avoid / specialist",
        "details": "Usually avoid; refer to SPC and renal/cardiology advice."
      }
    ],
    "notes": [
      "Monitor for genital infections, volume depletion and DKA risk."
    ]
  },

  {
    "id": "ramipril",
    "name": "Ramipril",
    "searchTerms": ["ramipril"],
    "className": "ACE inhibitor",
    "tags": ["HF", "Hypertension"],
    "usualDose": "2.5–10 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard titration",
        "details": "Titrate to target with creatinine/potassium checks."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Start low, go slow",
        "details": "Start at low dose and titrate cautiously; stop/tweak if creatinine rises >~30% or K⁺ increases."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Careful use",
        "details": "Very low doses with frequent monitoring; consider nephrology/cardiology advice."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Specialist decision",
        "details": "Use only on specialist advice."
      }
    ],
    "notes": [
      "Apply sick-day rules – hold during dehydration/AKI risk."
    ]
  },
  {
    "id": "lisinopril",
    "name": "Lisinopril",
    "searchTerms": ["lisinopril"],
    "className": "ACE inhibitor",
    "tags": ["Hypertension", "HF"],
    "usualDose": "5–40 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use usual titration with monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Lower start",
        "details": "Start at low dose and titrate slowly with U&E checks."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist / cautious",
        "details": "Low-dose use only with close monitoring and often specialist input."
      }
    ],
    "notes": [
      "Monitoring strategy similar to ramipril."
    ]
  },
  {
    "id": "losartan",
    "name": "Losartan",
    "searchTerms": ["losartan", "cozaar"],
    "className": "ARB",
    "tags": ["Hypertension", "HF", "Diabetic nephropathy"],
    "usualDose": "25–100 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual doses with U&E monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Lower starting dose",
        "details": "Start at 25–50 mg and titrate slowly."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist / cautious",
        "details": "Low doses only with frequent monitoring or specialist advice."
      }
    ],
    "notes": [
      "ARB monitoring and cautions similar to ACE inhibitors."
    ]
  },
  {
    "id": "candesartan",
    "name": "Candesartan",
    "searchTerms": ["candesartan"],
    "className": "ARB",
    "tags": ["HF", "Hypertension"],
    "usualDose": "4–32 mg once daily, indication-dependent.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use usual titration with renal and potassium checks."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Cautious titration",
        "details": "Use lower starting doses and titrate carefully."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist",
        "details": "Low-dose use only with frequent U&E monitoring / specialist advice."
      }
    ],
    "notes": [
      "Commonly used in HF; follow local HF titration protocol if available."
    ]
  },
  {
    "id": "bisoprolol",
    "name": "Bisoprolol",
    "searchTerms": ["bisoprolol"],
    "className": "Beta-1 selective beta-blocker",
    "tags": ["HF", "Hypertension"],
    "usualDose": "Heart failure: 1.25–10 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard titration",
        "details": "Titrate per HF/HTN protocol."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "No formal change",
        "details": "Usually no structured dose change, but titrate slowly in frail/CKD."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Caution",
        "details": "Monitor closely for bradycardia/hypotension; specialist advice in advanced CKD."
      }
    ],
    "notes": [
      "Partly renally cleared; accumulation may contribute to bradycardia in CKD."
    ]
  },
  {
    "id": "furosemide",
    "name": "Furosemide",
    "searchTerms": ["furosemide", "frusemide"],
    "className": "Loop diuretic",
    "tags": ["HF", "Oedema"],
    "usualDose": "20–80 mg once or twice daily; higher doses in CKD.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use lowest effective dose with monitoring of U&E and volume status."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Higher doses often",
        "details": "May need higher doses; monitor for AKI and electrolyte disturbance."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Specialist titration",
        "details": "High doses and/or IV often required; usually titrated by HF/renal teams."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "Individualised",
        "details": "Use only with specialist guidance."
      }
    ],
    "notes": [
      "Avoid over-diuresis; assess weight, JVP, BP and renal function."
    ]
  },
  {
    "id": "spironolactone",
    "name": "Spironolactone",
    "searchTerms": ["spironolactone"],
    "className": "Aldosterone antagonist",
    "tags": ["HF", "Hyperkalaemia risk"],
    "usualDose": "HF: typically 25–50 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard low dose",
        "details": "Use usual HF doses with U&E monitoring."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45–59",
        "category": "Caution",
        "details": "Consider 25 mg on alternate days and closer K⁺ monitoring."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44",
        "category": "High hyperkalaemia risk",
        "details": "Often avoid or use very low doses with frequent U&E."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Generally avoid",
        "details": "Usually avoided outside specialist settings."
      }
    ],
    "notes": [
      "Stop or reduce if K⁺ rises or creatinine increases significantly."
    ]
  },
  {
    "id": "atorvastatin",
    "name": "Atorvastatin",
    "searchTerms": ["atorvastatin"],
    "className": "Statin",
    "tags": ["Lipids"],
    "usualDose": "10–80 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "Generally no structured dose change; use usual CKD dose recommendations (often 20 mg+ for secondary prevention)."
      }
    ],
    "notes": [
      "Monitor for myopathy; adjust if CK or symptoms problematic."
    ]
  },
  {
    "id": "simvastatin",
    "name": "Simvastatin",
    "searchTerms": ["simvastatin"],
    "className": "Statin",
    "tags": ["Lipids"],
    "usualDose": "10–40 mg once daily in the evening.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual doses with routine monitoring."
      },
      {
        "min": null,
        "max": 60,
        "label": "eGFR < 60",
        "category": "No major change",
        "details": "Often no formal adjustment, but some guidance suggests lower starting doses in advanced CKD."
      }
    ],
    "notes": [
      "Be aware of drug interactions and myopathy risk."
    ]
  },

  {
    "id": "apixaban",
    "name": "Apixaban",
    "searchTerms": ["apixaban", "eliquis", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "AF", "VTE"],
    "usualDose": "AF: 5 mg twice daily, or 2.5 mg twice daily if dose-reduction criteria.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl ≥ 50",
        "category": "Standard dosing",
        "details": "Use labelled dose for indication."
      },
      {
        "min": 30,
        "max": 50,
        "label": "CrCl 30–49",
        "category": "Caution / possible reduction",
        "details": "Often reduced dose in AF if criteria met; check SPC/SPS/local DOAC protocol."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29",
        "category": "Reduced dose / specialist",
        "details": "AF: usually 2.5 mg bd with caution; VTE often specialist-only decision."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Avoid",
        "details": "Most UK guidance: avoid DOACs and consider warfarin or no anticoagulation."
      }
    ],
    "notes": [
      "Always use Cockcroft–Gault CrCl, not eGFR, for DOAC dosing."
    ]
  },
  {
    "id": "rivaroxaban",
    "name": "Rivaroxaban",
    "searchTerms": ["rivaroxaban", "xarelto", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "AF", "VTE"],
    "usualDose": "AF: 20 mg od with food; 15 mg od if CrCl 15–49.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl ≥ 50",
        "category": "Standard",
        "details": "Use labelled dose for AF/VTE."
      },
      {
        "min": 15,
        "max": 50,
        "label": "CrCl 15–49",
        "category": "Reduced dose",
        "details": "AF: 15 mg od; check SPC and SPS for other indications."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15",
        "category": "Avoid",
        "details": "Avoid rivaroxaban; consider alternatives."
      }
    ],
    "notes": [
      "Assess bleeding risk and renal function regularly."
    ]
  },
  {
    "id": "edoxaban",
    "name": "Edoxaban",
    "searchTerms": ["edoxaban", "lixiana", "doac"],
    "className": "Direct factor Xa inhibitor",
    "tags": ["DOAC", "AF", "VTE"],
    "usualDose": "AF: 60 mg od; 30 mg od if CrCl 15–50, low weight or certain interactions.",
    "renalBands": [
      {
        "min": 50,
        "max": 95,
        "label": "CrCl 50–95",
        "category": "Standard",
        "details": "Use 60 mg od if other reduction criteria not met."
      },
      {
        "min": 15,
        "max": 50,
        "label": "CrCl 15–49",
        "category": "Reduced dose",
        "details": "Usually 30 mg od; check SPC."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15",
        "category": "Avoid",
        "details": "Avoid edoxaban; use alternative."
      }
    ],
    "notes": [
      "Avoid if CrCl > 95 mL/min in AF due to reduced efficacy."
    ]
  },
  {
    "id": "warfarin",
    "name": "Warfarin",
    "searchTerms": ["warfarin"],
    "className": "Vitamin K antagonist",
    "tags": ["Anticoagulant"],
    "usualDose": "Highly individualised to INR.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "INR-guided",
        "details": "No fixed renal adjustment; dose to INR within target range."
      }
    ],
    "notes": [
      "Bleeding risk higher in CKD; monitor INR and interactions closely."
    ]
  },

  {
    "id": "gabapentin",
    "name": "Gabapentin",
    "searchTerms": ["gabapentin", "neurontin"],
    "className": "Antiepileptic / neuropathic pain",
    "tags": ["Neuropathic pain", "Renally cleared"],
    "usualDose": "900–3600 mg/day in 3 doses in normal renal function.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "CrCl ≥ 60",
        "category": "Standard",
        "details": "Usual titration up to local max."
      },
      {
        "min": 30,
        "max": 60,
        "label": "CrCl 30–59",
        "category": "Moderate reduction",
        "details": "Reduce total daily dose and/or frequency (e.g. ~600–1800 mg/day)."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29",
        "category": "Significant reduction",
        "details": "Low doses (e.g. 300–600 mg/day) with slow titration."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist dosing",
        "details": "Very low or post-dialysis dosing only."
      }
    ],
    "notes": [
      "Accumulation causes sedation/ataxia; use CrCl rather than eGFR if possible."
    ]
  },
  {
    "id": "pregabalin",
    "name": "Pregabalin",
    "searchTerms": ["pregabalin", "lyrica"],
    "className": "Antiepileptic / neuropathic pain / GAD",
    "tags": ["Neuropathic pain", "Renally cleared"],
    "usualDose": "150–600 mg/day in 2–3 divided doses.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "CrCl ≥ 60",
        "category": "Standard",
        "details": "Use usual titration schedule."
      },
      {
        "min": 30,
        "max": 60,
        "label": "CrCl 30–59",
        "category": "Dose reduction",
        "details": "Lower maximum daily dose (e.g. up to ~300 mg/day)."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29",
        "category": "Marked reduction",
        "details": "Substantially reduced doses (e.g. up to ~150 mg/day)."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist",
        "details": "Very low/post-dialysis dosing only."
      }
    ],
    "notes": [
      "Accumulation increases sedation, dizziness and oedema; taper slowly when stopping."
    ]
  },
  {
    "id": "sertraline",
    "name": "Sertraline",
    "searchTerms": ["sertraline"],
    "className": "SSRI antidepressant",
    "tags": ["Depression", "Anxiety"],
    "usualDose": "50–200 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "Usually no structured dose change; start low and titrate by response."
      }
    ],
    "notes": [
      "Monitor for hyponatraemia, especially in older patients and CKD."
    ]
  },
  {
    "id": "mirtazapine",
    "name": "Mirtazapine",
    "searchTerms": ["mirtazapine"],
    "className": "NaSSA antidepressant",
    "tags": ["Depression"],
    "usualDose": "15–45 mg at night.",
    "renalBands": [
      {
        "min": 40,
        "max": null,
        "label": "eGFR ≥ 40",
        "category": "Standard",
        "details": "Usual dose range with clinical monitoring."
      },
      {
        "min": null,
        "max": 40,
        "label": "eGFR < 40",
        "category": "Caution",
        "details": "Consider lower doses and slower titration; monitor for sedation."
      }
    ],
    "notes": [
      "Can cause weight gain and sedation; useful for insomnia/poor appetite."
    ]
  },
  {
    "id": "venlafaxine",
    "name": "Venlafaxine",
    "searchTerms": ["venlafaxine"],
    "className": "SNRI antidepressant",
    "tags": ["Depression", "Anxiety"],
    "usualDose": "75–225 mg/day (immediate or modified-release).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual dose range as per BNF."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Dose reduction",
        "details": "Reduce total daily dose (e.g. by ~25–50%) and titrate slowly."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Further reduction",
        "details": "Use low doses only and monitor closely; consider alternatives in severe CKD."
      }
    ],
    "notes": [
      "Monitor BP and withdrawal symptoms on discontinuation."
    ]
  },
  {
    "id": "amitriptyline",
    "name": "Amitriptyline",
    "searchTerms": ["amitriptyline"],
    "className": "Tricyclic antidepressant",
    "tags": ["Depression", "Neuropathic pain"],
    "usualDose": "10–75 mg at night for pain (higher for depression under specialist care).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Clinical titration",
        "details": "No formal renal table; start low and titrate by tolerability, particularly in older adults/CKD."
      }
    ],
    "notes": [
      "Anticholinergic and cardiac side-effects limit use in frailer CKD patients."
    ]
  },

  {
    "id": "amoxicillin",
    "name": "Amoxicillin",
    "searchTerms": ["amoxicillin"],
    "className": "Aminopenicillin antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "500 mg tds (higher for severe infection).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual dose and interval."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) according to severity and local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 / dialysis",
        "category": "Further reduction",
        "details": "Lower dose or longer interval; seek renal/microbiology advice in severe infection."
      }
    ],
    "notes": [
      "Follow local antimicrobial guidance for indication and exact dosing."
    ]
  },
  {
    "id": "co-amoxiclav",
    "name": "Co-amoxiclav",
    "searchTerms": ["co-amoxiclav", "amoxicillin clavulanic"],
    "className": "Amoxicillin + clavulanic acid",
    "tags": ["Antibiotic"],
    "usualDose": "500/125 mg tds or 875/125 mg bd depending on prep.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual dosing per indication."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) as per BNF/local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 / dialysis",
        "category": "Further reduction",
        "details": "Consider alternative or further dose/interval reduction with specialist advice."
      }
    ],
    "notes": [
      "Monitor LFTs if prolonged course; be aware of cholestatic hepatitis risk."
    ]
  },
  {
    "id": "nitrofurantoin",
    "name": "Nitrofurantoin",
    "searchTerms": ["nitrofurantoin", "macrobid"],
    "className": "Urinary antibacterial",
    "tags": ["UTI"],
    "usualDose": "100 mg MR bd or 50 mg qds for 3–7 days.",
    "renalBands": [
      {
        "min": 45,
        "max": null,
        "label": "eGFR ≥ 45",
        "category": "Standard short course",
        "details": "Use for lower UTI only if no upper tract features."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44",
        "category": "Short course only",
        "details": "Some guidance allows short-course use if benefits outweigh risks; avoid prophylaxis."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Avoid due to poor urinary levels and higher toxicity risk."
      }
    ],
    "notes": [
      "Avoid in suspected pyelonephritis or sepsis."
    ]
  },
  {
    "id": "trimethoprim",
    "name": "Trimethoprim",
    "searchTerms": ["trimethoprim"],
    "className": "Dihydrofolate reductase inhibitor",
    "tags": ["UTI", "Hyperkalaemia risk"],
    "usualDose": "200 mg bd for 3–7 days (acute UTI).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual short course dosing."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Dose reduction",
        "details": "Reduce total dose or extend interval (e.g. 200 mg od)."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Avoid / specialist",
        "details": "Avoid if possible due to hyperkalaemia and creatinine rise."
      }
    ],
    "notes": [
      "Check K⁺ and creatinine if using in patients on ACEI/ARB/spironolactone."
    ]
  },
  {
    "id": "cefalexin",
    "name": "Cefalexin",
    "searchTerms": ["cefalexin", "cephalexin"],
    "className": "1st-generation cephalosporin",
    "tags": ["Antibiotic"],
    "usualDose": "500 mg bd–qds depending on indication.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50",
        "category": "Standard",
        "details": "Usual dose and frequency."
      },
      {
        "min": 10,
        "max": 50,
        "label": "eGFR 10–49",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) as per BNF/local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Further reduction",
        "details": "Low dose or longer interval; seek renal/micro advice in serious infection."
      }
    ],
    "notes": [
      "Watch for neurotoxicity at very low eGFR and high doses."
    ]
  },

  {
    "id": "digoxin",
    "name": "Digoxin",
    "searchTerms": ["digoxin"],
    "className": "Cardiac glycoside",
    "tags": ["HF", "Rate control", "Narrow therapeutic index"],
    "usualDose": "62.5–250 micrograms od according to age, renal function and indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard low-ish dosing",
        "details": "Use lower doses in older adults; monitor levels if concern."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Dose reduction",
        "details": "Often 62.5–125 micrograms od or on alternate days; check levels if possible."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Marked reduction",
        "details": "Very low doses (e.g. 62.5 micrograms od/alt days); monitor for toxicity."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Specialist dosing",
        "details": "Dose only with level monitoring and specialist supervision."
      }
    ],
    "notes": [
      "Toxicity risk rises in CKD, hypokalaemia and hypomagnesaemia; review interacting drugs."
    ]
  },
    {
    "id": "pioglitazone",
    "name": "Pioglitazone",
    "searchTerms": ["pioglitazone", "actos"],
    "className": "Thiazolidinedione",
    "tags": ["Diabetes"],
    "usualDose": "15–45 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "Dose is not primarily renally determined; use usual doses but avoid fluid overload in HF or advanced CKD."
      }
    ],
    "notes": [
      "Monitor weight and oedema; avoid in heart failure or high fracture risk.",
      "Review for bladder cancer risk factors as per SPC/local guidance."
    ]
  },
  {
    "id": "sitagliptin",
    "name": "Sitagliptin",
    "searchTerms": ["sitagliptin", "januvia"],
    "className": "DPP-4 inhibitor",
    "tags": ["Diabetes", "Renally cleared"],
    "usualDose": "100 mg once daily in normal renal function.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50",
        "category": "Standard",
        "details": "100 mg once daily."
      },
      {
        "min": 30,
        "max": 50,
        "label": "eGFR 30–49",
        "category": "Dose reduction",
        "details": "50 mg once daily."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Further reduction",
        "details": "25 mg once daily."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "25 mg once daily (label-based)",
        "details": "Use 25 mg once daily with monitoring; check SPC/local guidance."
      }
    ],
    "notes": [
      "Low hypoglycaemia risk when used without sulfonylurea/insulin.",
      "Adjust doses of combination products accordingly."
    ]
  },
  {
    "id": "linagliptin",
    "name": "Linagliptin",
    "searchTerms": ["linagliptin", "trajenta"],
    "className": "DPP-4 inhibitor",
    "tags": ["Diabetes"],
    "usualDose": "5 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Predominantly non-renal clearance; same dose across eGFR ranges as per SPC."
      }
    ],
    "notes": [
      "Low hypoglycaemia risk unless combined with sulfonylurea/insulin.",
      "Useful option in advanced CKD when DPP-4 inhibition is required."
    ]
  },
  {
    "id": "amlodipine",
    "name": "Amlodipine",
    "searchTerms": ["amlodipine"],
    "className": "Dihydropyridine calcium-channel blocker",
    "tags": ["Hypertension", "Angina"],
    "usualDose": "5–10 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "Not significantly renally cleared; use usual doses with BP and oedema monitoring."
      }
    ],
    "notes": [
      "Peripheral oedema is common; may worsen with advanced CKD.",
      "Avoid abrupt withdrawal in angina."
    ]
  },
  {
    "id": "doxazosin",
    "name": "Doxazosin",
    "searchTerms": ["doxazosin"],
    "className": "Alpha-1 blocker",
    "tags": ["Hypertension", "BPH"],
    "usualDose": "1–16 mg once daily (or modified-release) depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "Metabolised hepatically; use usual doses but start low and titrate carefully in older people and CKD."
      }
    ],
    "notes": [
      "Monitor for postural hypotension and falls.",
      "Useful as add-on therapy in resistant hypertension."
    ]
  },
  {
    "id": "indapamide",
    "name": "Indapamide",
    "searchTerms": ["indapamide"],
    "className": "Thiazide-like diuretic",
    "tags": ["Hypertension"],
    "usualDose": "1.5 mg MR once daily or 2.5 mg once daily.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual doses may be used with U&E monitoring."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Reduced efficacy",
        "details": "Less effective as a diuretic in eGFR < 30; consider loop diuretic instead for fluid control."
      }
    ],
    "notes": [
      "Monitor sodium, potassium and urate.",
      "Use cautiously with other drugs causing hyponatraemia."
    ]
  },
  {
    "id": "bendroflumethiazide",
    "name": "Bendroflumethiazide",
    "searchTerms": ["bendroflumethiazide"],
    "className": "Thiazide diuretic",
    "tags": ["Hypertension"],
    "usualDose": "2.5 mg once daily for hypertension (higher doses for oedema).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "May be used for hypertension with monitoring of electrolytes."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Generally avoid",
        "details": "Ineffective as diuretic and increased risk of toxicity; loop diuretic preferred for oedema."
      }
    ],
    "notes": [
      "Monitor sodium and potassium, particularly in older adults.",
      "Can increase urate and glucose."
    ]
  },
  {
    "id": "sacubitril-valsartan",
    "name": "Sacubitril / valsartan",
    "searchTerms": ["sacubitril", "entresto", "sacubitril valsartan"],
    "className": "ARNI (angiotensin receptor–neprilysin inhibitor)",
    "tags": ["Heart failure"],
    "usualDose": "Target 97/103 mg twice daily after titration from lower strengths.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard initiation",
        "details": "Start at appropriate strength and titrate to target as tolerated, with close U&E monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Lower start",
        "details": "Start at lowest strength and titrate cautiously with frequent checks of creatinine and potassium."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Specialist use",
        "details": "Use only under specialist HF supervision with close U&E monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "Avoid",
        "details": "Generally avoided in severe renal impairment; seek specialist advice."
      }
    ],
    "notes": [
      "Must not be co-administered with ACE inhibitors (36-hour washout required).",
      "Monitor for hypotension, hyperkalaemia and renal dysfunction."
    ]
  },
  {
    "id": "aspirin-lowdose",
    "name": "Aspirin (75 mg for CV prevention)",
    "searchTerms": ["aspirin", "low-dose aspirin"],
    "className": "Antiplatelet",
    "tags": ["Antiplatelet"],
    "usualDose": "75 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal dose adjustment",
        "details": "Low-dose aspirin is not usually renally adjusted, but bleeding risk is higher in CKD."
      }
    ],
    "notes": [
      "Consider gastroprotection in high-risk patients.",
      "Use with caution in advanced CKD with bleeding tendency."
    ]
  },
  {
    "id": "clopidogrel",
    "name": "Clopidogrel",
    "searchTerms": ["clopidogrel"],
    "className": "P2Y12 inhibitor antiplatelet",
    "tags": ["Antiplatelet"],
    "usualDose": "75 mg once daily (after loading dose in ACS/PCI).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "No usual dose change with renal impairment, but bleeding risk is increased in CKD."
      }
    ],
    "notes": [
      "Assess bleeding vs thrombotic risk carefully in advanced CKD.",
      "Avoid use with proton pump inhibitors that strongly inhibit CYP2C19 unless necessary."
    ]
  },
  {
    "id": "rosuvastatin",
    "name": "Rosuvastatin",
    "searchTerms": ["rosuvastatin", "crestor"],
    "className": "Statin",
    "tags": ["Lipids"],
    "usualDose": "5–40 mg once daily depending on indication and risk.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use labelled dose range with monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Lower starting dose",
        "details": "Start at low dose (e.g. 5–10 mg) and titrate; higher doses may be used with caution."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Reduced maximum",
        "details": "Maximum dose is reduced; check SPC/BNF for current maxima (e.g. 10–20 mg)."
      }
    ],
    "notes": [
      "Monitor for muscle symptoms and CK if indicated.",
      "Consider alternative statin if intolerance."
    ]
  },
  {
    "id": "ezetimibe",
    "name": "Ezetimibe",
    "searchTerms": ["ezetimibe"],
    "className": "Cholesterol absorption inhibitor",
    "tags": ["Lipids"],
    "usualDose": "10 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change usually required in CKD."
      }
    ],
    "notes": [
      "Often used as add-on to statin therapy.",
      "Monitor LFTs when combined with statin."
    ]
  },
  {
    "id": "salbutamol-inhaled",
    "name": "Salbutamol (inhaled)",
    "searchTerms": ["salbutamol", "ventolin"],
    "className": "Short-acting beta-2 agonist",
    "tags": ["Asthma", "COPD"],
    "usualDose": "100–200 micrograms prn by inhaler.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Inhaled doses are not renally adjusted; monitor potassium if frequent high-dose use in CKD."
      }
    ],
    "notes": [
      "High-dose nebulised therapy can cause hypokalaemia; monitor in severe CKD/AKI."
    ]
  },
  {
    "id": "tiotropium",
    "name": "Tiotropium (inhaled)",
    "searchTerms": ["tiotropium", "spiriva"],
    "className": "Long-acting muscarinic antagonist",
    "tags": ["COPD", "Asthma"],
    "usualDose": "Once daily inhaled dose according to device.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual dose."
      },
      {
        "min": null,
        "max": 60,
        "label": "eGFR < 60",
        "category": "Caution",
        "details": "Small increase in systemic exposure; monitor for anticholinergic side effects but usually no dose change."
      }
    ],
    "notes": [
      "Use with caution in urinary retention or narrow-angle glaucoma."
    ]
  },
  {
    "id": "budesonide-formoterol",
    "name": "Budesonide/formoterol (inhaler)",
    "searchTerms": ["budesonide", "formoterol", "symbicort"],
    "className": "ICS/LABA combination",
    "tags": ["Asthma", "COPD"],
    "usualDose": "Dose depends on strength and MART vs fixed regimen.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Inhaled combination not renally adjusted."
      }
    ],
    "notes": [
      "Follow national asthma/COPD guidance for dose selection.",
      "Rinse mouth after use to reduce thrush risk."
    ]
  },
  {
    "id": "omeprazole",
    "name": "Omeprazole",
    "searchTerms": ["omeprazole"],
    "className": "Proton pump inhibitor",
    "tags": ["PPI", "GI"],
    "usualDose": "20–40 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No formal dose change required in CKD."
      }
    ],
    "notes": [
      "Long-term use associated with hypomagnesaemia, fractures and C. difficile; review need regularly."
    ]
  },
  {
    "id": "lansoprazole",
    "name": "Lansoprazole",
    "searchTerms": ["lansoprazole"],
    "className": "Proton pump inhibitor",
    "tags": ["PPI", "GI"],
    "usualDose": "15–30 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change usually required."
      }
    ],
    "notes": [
      "As with other PPIs, periodically review long-term therapy."
    ]
  },
  {
    "id": "loperamide",
    "name": "Loperamide",
    "searchTerms": ["loperamide", "imodium"],
    "className": "Antidiarrhoeal",
    "tags": ["GI"],
    "usualDose": "Up to 16 mg/day in divided doses for acute diarrhoea.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Not renally dose-adjusted; avoid in acute colitis and use cautiously in hepatic impairment."
      }
    ],
    "notes": [
      "Avoid overuse; investigate underlying cause if symptoms persist.",
      "Risk of serious cardiac events at high doses."
    ]
  },
  {
    "id": "ondansetron",
    "name": "Ondansetron",
    "searchTerms": ["ondansetron", "zofran"],
    "className": "5-HT3 antagonist antiemetic",
    "tags": ["Antiemetic"],
    "usualDose": "4–8 mg 1–3 times daily orally for nausea/vomiting.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change in mild–moderate renal impairment; in severe CKD usual doses are often used but monitor for QT prolongation."
      }
    ],
    "notes": [
      "Use cautiously with other QT-prolonging drugs or electrolyte disturbances."
    ]
  },
  {
    "id": "levothyroxine",
    "name": "Levothyroxine",
    "searchTerms": ["levothyroxine", "thyroxine"],
    "className": "Thyroid hormone replacement",
    "tags": ["Endocrine"],
    "usualDose": "Individualised; typical maintenance 50–200 micrograms once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "TSH-guided dosing",
        "details": "No formal renal adjustment; dose to TSH and clinical response."
      }
    ],
    "notes": [
      "TSH targets may differ in elderly or cardiac disease.",
      "Take on empty stomach, separate from calcium/iron supplements."
    ]
  },
  {
    "id": "carbimazole",
    "name": "Carbimazole",
    "searchTerms": ["carbimazole"],
    "className": "Antithyroid drug",
    "tags": ["Endocrine"],
    "usualDose": "10–40 mg daily in divided doses initially, then titrated.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No formal renal dose change; titrate to thyroid function tests."
      }
    ],
    "notes": [
      "Warn about agranulocytosis symptoms (sore throat, fever, mouth ulcers).",
      "Monitor FBC and LFTs if clinically indicated."
    ]
  },
  {
    "id": "alendronic-acid",
    "name": "Alendronic acid",
    "searchTerms": ["alendronate", "alendronic acid"],
    "className": "Bisphosphonate",
    "tags": ["Bone health", "Osteoporosis"],
    "usualDose": "70 mg once weekly (or 10 mg daily) for osteoporosis.",
    "renalBands": [
      {
        "min": 35,
        "max": null,
        "label": "eGFR ≥ 35",
        "category": "Standard",
        "details": "Usual dose may be used if eGFR is 35 or above."
      },
      {
        "min": null,
        "max": 35,
        "label": "eGFR < 35",
        "category": "Avoid",
        "details": "Generally avoided when eGFR is below 35 mL/min; consider alternative osteoporosis treatments."
      }
    ],
    "notes": [
      "Ensure adequate calcium/vitamin D and correct hypocalcaemia before treatment.",
      "Follow administration instructions to reduce oesophageal irritation."
    ]
  },
  {
    "id": "colecalciferol",
    "name": "Colecalciferol (vitamin D3)",
    "searchTerms": ["colecalciferol", "vitamin d"],
    "className": "Vitamin D supplement",
    "tags": ["Bone health"],
    "usualDose": "Loading or maintenance regimens vary (e.g. 800–2000 IU daily).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No standard renal adjustment",
        "details": "Dose is guided by vitamin D level and local CKD bone-mineral guidance rather than eGFR alone."
      }
    ],
    "notes": [
      "In advanced CKD, activated vitamin D analogues may be required; follow renal team guidance."
    ]
  },
  {
    "id": "valproate",
    "name": "Sodium valproate",
    "searchTerms": ["sodium valproate", "epilim", "valproate"],
    "className": "Antiepileptic / mood stabiliser",
    "tags": ["Epilepsy", "Bipolar"],
    "usualDose": "Individualised; often 600–2000 mg/day in divided doses.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "Not significantly renally cleared; use usual doses but consider lower starting dose in frail CKD."
      }
    ],
    "notes": [
      "Serious hepatic, haematological and teratogenic risks; follow MHRA guidance.",
      "Avoid in women of childbearing potential unless absolutely necessary and within Pregnancy Prevention Programme."
    ]
  },
  {
    "id": "lamotrigine",
    "name": "Lamotrigine",
    "searchTerms": ["lamotrigine"],
    "className": "Antiepileptic / mood stabiliser",
    "tags": ["Epilepsy", "Bipolar"],
    "usualDose": "Varies by regimen and co-medication; usually 100–400 mg/day.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard titration",
        "details": "Use usual titration schedule guided by seizure control and side effects."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Caution",
        "details": "Consider slower titration and lower maintenance doses; monitor for toxicity."
      }
    ],
    "notes": [
      "Warn about rash and Stevens–Johnson syndrome.",
      "Check interactions with valproate and enzyme inducers."
    ]
  },
  {
    "id": "levetiracetam",
    "name": "Levetiracetam",
    "searchTerms": ["levetiracetam", "keppra"],
    "className": "Antiepileptic",
    "tags": ["Epilepsy", "Renally cleared"],
    "usualDose": "500–3000 mg/day in 2 divided doses in normal renal function.",
    "renalBands": [
      {
        "min": 80,
        "max": null,
        "label": "CrCl ≥ 80",
        "category": "Standard",
        "details": "Usual dose range according to indication."
      },
      {
        "min": 50,
        "max": 80,
        "label": "CrCl 50–79",
        "category": "Mild reduction",
        "details": "Slight dose reduction may be considered; check SPC for exact schedules."
      },
      {
        "min": 30,
        "max": 50,
        "label": "CrCl 30–49",
        "category": "Moderate reduction",
        "details": "Further reduce total daily dose; for example 250–750 mg twice daily depending on indication."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15–29",
        "category": "Marked reduction",
        "details": "Lower doses such as 250–500 mg twice daily; check SPC/local guidance."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist dosing",
        "details": "Low daily doses with post-dialysis supplementation as per specialist guidance."
      }
    ],
    "notes": [
      "Monitor mood and behavioural changes.",
      "Adjust dose promptly if renal function changes."
    ]
  },
  {
    "id": "carbamazepine",
    "name": "Carbamazepine",
    "searchTerms": ["carbamazepine", "tegretol"],
    "className": "Antiepileptic",
    "tags": ["Epilepsy", "Neuropathic pain"],
    "usualDose": "Usually 400–1200 mg/day in divided doses.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Clinical titration",
        "details": "No simple renal table; titrate to clinical response and serum levels if needed, using lower doses in frail CKD."
      }
    ],
    "notes": [
      "Enzyme inducer with many interactions; monitor sodium and FBC.",
      "Hyponatraemia is more common in older people and CKD."
    ]
  },
  {
    "id": "quetiapine",
    "name": "Quetiapine",
    "searchTerms": ["quetiapine", "seroquel"],
    "className": "Atypical antipsychotic",
    "tags": ["Psychosis", "Bipolar", "Depression (augmentation)"],
    "usualDose": "Wide range depending on indication; e.g. 50–800 mg/day.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "No routine renal dose change; start low and titrate carefully in CKD."
      }
    ],
    "notes": [
      "Monitor for metabolic syndrome, QT prolongation and sedation.",
      "Use lowest effective dose, particularly in elderly CKD patients."
    ]
  },
  {
    "id": "olanzapine",
    "name": "Olanzapine",
    "searchTerms": ["olanzapine", "zyprexa"],
    "className": "Atypical antipsychotic",
    "tags": ["Psychosis", "Bipolar"],
    "usualDose": "5–20 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Dose is not routinely adjusted for CKD, but use lower doses and careful titration in frail patients."
      }
    ],
    "notes": [
      "High risk of weight gain, metabolic syndrome and sedation.",
      "Monitor glucose and lipids regularly."
    ]
  },
  {
    "id": "risperidone",
    "name": "Risperidone",
    "searchTerms": ["risperidone"],
    "className": "Atypical antipsychotic",
    "tags": ["Psychosis"],
    "usualDose": "Commonly 2–6 mg/day in divided doses.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual dosing range may be used."
      },
      {
        "min": null,
        "max": 60,
        "label": "eGFR < 60",
        "category": "Lower starting dose",
        "details": "Use reduced starting doses and slower titration in moderate–severe CKD."
      }
    ],
    "notes": [
      "Monitor for extrapyramidal symptoms and metabolic effects.",
      "Use carefully in patients with cerebrovascular disease."
    ]
  },
  {
    "id": "tamsulosin",
    "name": "Tamsulosin",
    "searchTerms": ["tamsulosin"],
    "className": "Alpha-1 blocker (uroselective)",
    "tags": ["BPH", "Urology"],
    "usualDose": "400 micrograms once daily.",
    "renalBands": [
      {
        "min": 10,
        "max": null,
        "label": "eGFR ≥ 10",
        "category": "Standard",
        "details": "No usual dose change; monitor postural BP in older adults."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Caution",
        "details": "Limited data in very severe CKD; use with caution and monitor."
      }
    ],
    "notes": [
      "May cause postural hypotension; advise patients about dizziness/falls.",
      "Can contribute to intraoperative floppy iris syndrome in cataract surgery."
    ]
  },
  {
    "id": "finasteride",
    "name": "Finasteride",
    "searchTerms": ["finasteride"],
    "className": "5-alpha-reductase inhibitor",
    "tags": ["BPH"],
    "usualDose": "5 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change typically required in CKD."
      }
    ],
    "notes": [
      "PSA falls by about 50% on treatment; interpret results accordingly.",
      "Teratogenic to male fetus; women of childbearing potential should avoid handling crushed tablets."
    ]
  },
  {
    "id": "oxybutynin",
    "name": "Oxybutynin",
    "searchTerms": ["oxybutynin"],
    "className": "Antimuscarinic for overactive bladder",
    "tags": ["OAB", "Urology"],
    "usualDose": "2.5–5 mg two to three times daily (or modified-release once daily).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "No standard dose adjustment but start low and titrate with caution in frail CKD patients."
      }
    ],
    "notes": [
      "Anticholinergic burden is significant; consider alternatives in older people with CKD.",
      "Monitor for cognitive impairment and constipation."
    ]
  },
  {
    "id": "mirabegron",
    "name": "Mirabegron",
    "searchTerms": ["mirabegron", "betmiga"],
    "className": "Beta-3 agonist for overactive bladder",
    "tags": ["OAB", "Urology"],
    "usualDose": "Usually 50 mg once daily (25 mg in some groups).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard dosing",
        "details": "50 mg once daily."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Standard or reduced dose",
        "details": "50 mg once daily usually acceptable; some patients may start at 25 mg if frail or on interacting drugs."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15–29",
        "category": "Dose reduction",
        "details": "Maximum 25 mg once daily as per SPC in moderate renal impairment with certain risk factors."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "Avoid or specialist",
        "details": "Generally avoid in severe renal impairment; check SPC for exact restrictions."
      }
    ],
    "notes": [
      "Can raise blood pressure; avoid uncontrolled hypertension.",
      "Useful alternative when antimuscarinics are poorly tolerated."
    ]
  },
    {
    "id": "amoxicillin",
    "name": "Amoxicillin",
    "searchTerms": ["amoxicillin"],
    "className": "Penicillin antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "250–500 mg three times daily (higher in severe infections).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Use usual dosing."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Dose reduction",
        "details": "Reduce dosing frequency (e.g. 500 mg twice daily)."
      }
    ],
    "notes": [
      "Generally well tolerated; adjust dosing in severe impairment.",
      "Safe in pregnancy and breastfeeding."
    ]
  },
  {
    "id": "co-amoxiclav",
    "name": "Co-amoxiclav",
    "searchTerms": ["coamoxiclav", "augmentin"],
    "className": "Penicillin + beta-lactamase inhibitor",
    "tags": ["Antibiotic"],
    "usualDose": "500/125 mg three times daily.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual dose can be used."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29",
        "category": "Dose reduction",
        "details": "Consider 500/125 mg twice daily (BNF-based)."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Further reduction",
        "details": "500/125 mg once daily or specialist advice depending on severity."
      }
    ],
    "notes": [
      "Avoid the 875 mg strength in CKD due to accumulation risk.",
      "Monitor LFTs with prolonged use."
    ]
  },
  {
    "id": "phenoxymethylpenicillin",
    "name": "Phenoxymethylpenicillin (Pen V)",
    "searchTerms": ["penicillin v", "phenoxymethylpenicillin"],
    "className": "Penicillin antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "250–500 mg four times daily depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Standard",
        "details": "No dose adjustment usually required."
      }
    ],
    "notes": [
      "Preferred for tonsillitis/erysipelas in adults and children."
    ]
  },
  {
    "id": "flucloxacillin",
    "name": "Flucloxacillin",
    "searchTerms": ["flucloxacillin"],
    "className": "Penicillin antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "500 mg four times daily.",
    "renalBands": [
      {
        "min": 10,
        "max": null,
        "label": "eGFR ≥ 10",
        "category": "Standard",
        "details": "Usual dose is appropriate."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Caution",
        "details": "No formal renal adjustment but monitor hepatic function and for neurotoxicity in severe renal failure."
      }
    ],
    "notes": [
      "Useful for cellulitis and MSSA infections.",
      "Take on an empty stomach for better absorption."
    ]
  },
  {
    "id": "clarithromycin",
    "name": "Clarithromycin",
    "searchTerms": ["clarithromycin"],
    "className": "Macrolide antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "250–500 mg twice daily.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Usual dosing allowed."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Dose reduction",
        "details": "Reduce dose by 50% or increase dosing interval."
      }
    ],
    "notes": [
      "Major CYP3A4 interactions; check carefully.",
      "QT prolongation risk increases in CKD."
    ]
  },
  {
    "id": "azithromycin",
    "name": "Azithromycin",
    "searchTerms": ["azithromycin"],
    "className": "Macrolide antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "500 mg once daily for 3 days (or other regimens depending on indication).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No formal adjustment required."
      }
    ],
    "notes": [
      "Use caution with QT-prolonging drugs.",
      "Less CYP interaction than clarithromycin."
    ]
  },
  {
    "id": "doxycycline",
    "name": "Doxycycline",
    "searchTerms": ["doxycycline"],
    "className": "Tetracycline antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "200 mg day 1 then 100 mg daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal function",
        "category": "No adjustment",
        "details": "Preferred tetracycline in CKD as elimination is non-renal."
      }
    ],
    "notes": [
      "Avoid in pregnancy & in children under 12.",
      "Minimise sun exposure."
    ]
  },
  {
    "id": "ciprofloxacin",
    "name": "Ciprofloxacin",
    "searchTerms": ["cipro", "ciprofloxacin"],
    "className": "Fluoroquinolone antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "250–500 mg twice daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Use usual dose."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Mild reduction",
        "details": "Reduce dose (e.g. 250 mg twice daily or extend interval)."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Moderate reduction",
        "details": "Reduce further – check BNF/SPC."
      }
    ],
    "notes": [
      "Tendinopathy risk increased in CKD, older adults & steroid use.",
      "QT prolongation risk."
    ]
  },
  {
    "id": "nitrofurantoin",
    "name": "Nitrofurantoin",
    "searchTerms": ["nitrofurantoin"],
    "className": "Urinary antibiotic",
    "tags": ["UTI"],
    "usualDose": "100 mg twice daily (or 50 mg four times daily).",
    "renalBands": [
      {
        "min": 45,
        "max": null,
        "label": "eGFR ≥ 45",
        "category": "Standard",
        "details": "Usual dosing can be used."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30–44",
        "category": "Conditional use",
        "details": "Short-course (3–7 days) may be used for lower UTI only if benefits outweigh risks (MHRA)."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Ineffective and risk of toxicity; avoid."
      }
    ],
    "notes": [
      "Not for upper UTI or pyelonephritis.",
      "Check local UTI guidelines."
    ]
  },
  {
    "id": "trimethoprim",
    "name": "Trimethoprim",
    "searchTerms": ["trimethoprim"],
    "className": "Folate antagonist antibiotic",
    "tags": ["UTI"],
    "usualDose": "200 mg twice daily for 3 days.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR ≥ 30",
        "category": "Standard",
        "details": "Use usual dose."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Dose reduction",
        "details": "Reduce dose/frequency; avoid if possible due to hyperkalaemia risk."
      }
    ],
    "notes": [
      "Hyperkalaemia risk increased in CKD and with ACEi/ARB/spironolactone.",
      "Avoid in pregnancy."
    ]
  },
  {
    "id": "metronidazole",
    "name": "Metronidazole",
    "searchTerms": ["metronidazole", "flagyl"],
    "className": "Nitroimidazole antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "400 mg twice or three times daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal function",
        "category": "No adjustment",
        "details": "Use usual dosing."
      }
    ],
    "notes": [
      "Reduce dose only in severe hepatic impairment.",
      "Avoid alcohol due to disulfiram-like reaction."
    ]
  },
  {
    "id": "cefalexin",
    "name": "Cefalexin",
    "searchTerms": ["cefalexin", "cephalexin"],
    "className": "Cephalosporin antibiotic",
    "tags": ["Antibiotic"],
    "usualDose": "250–500 mg every 6–8 hours.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50",
        "category": "Standard",
        "details": "Usual dosing."
      },
      {
        "min": 10,
        "max": 50,
        "label": "eGFR 10–49",
        "category": "Reduction",
        "details": "Reduce frequency (e.g. 500 mg twice daily)."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Further reduction",
        "details": "Lower dose or interval; check BNF/SPC."
      }
    ],
    "notes": [
      "Good for pregnancy-safe UTI and SSTI.",
      "May cause GI upset."
    ]
  },
  {
    "id": "acyclovir",
    "name": "Aciclovir",
    "searchTerms": ["aciclovir", "acyclovir"],
    "className": "Antiviral",
    "tags": ["HSV", "VZV"],
    "usualDose": "200–800 mg depending on indication.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50",
        "category": "Standard",
        "details": "Usual dose."
      },
      {
        "min": 25,
        "max": 50,
        "label": "eGFR 25–49",
        "category": "Reduction",
        "details": "Reduce frequency (e.g. every 12 hours)."
      },
      {
        "min": 10,
        "max": 25,
        "label": "eGFR 10–24",
        "category": "Further reduction",
        "details": "Increase interval (e.g. every 24 hours)."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Marked reduction",
        "details": "Use extended intervals; check SPC."
      }
    ],
    "notes": [
      "Hydrate well to reduce crystalluria risk.",
      "Neurotoxicity risk increases in severe CKD."
    ]
  },
  {
    "id": "valaciclovir",
    "name": "Valaciclovir",
    "searchTerms": ["valaciclovir", "valacyclovir"],
    "className": "Antiviral",
    "tags": ["HSV", "VZV"],
    "usualDose": "500 mg twice daily for HSV; higher for VZV.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR ≥ 50",
        "category": "Standard",
        "details": "Usual dose."
      },
      {
        "min": 30,
        "max": 50,
        "label": "eGFR 30–49",
        "category": "Mild reduction",
        "details": "Reduce frequency."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10–29",
        "category": "Moderate reduction",
        "details": "Lower dose/frequency based on indication."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Severe reduction",
        "details": "Marked dose reduction required; check SPC."
      }
    ],
    "notes": [
      "Better oral bioavailability than aciclovir.",
      "Hydration important."
    ]
  },
  {
    "id": "prednisolone",
    "name": "Prednisolone",
    "searchTerms": ["prednisolone"],
    "className": "Corticosteroid",
    "tags": ["Steroid"],
    "usualDose": "Varies by indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal ranges",
        "category": "No dose change",
        "details": "Steroid doses depend on indication, not renal function."
      }
    ],
    "notes": [
      "Monitor BP, glucose, mood and infection risk.",
      "Taper slowly after long-term use."
    ]
  },
  {
    "id": "methotrexate",
    "name": "Methotrexate",
    "searchTerms": ["methotrexate"],
    "className": "DMARD",
    "tags": ["Rheumatology"],
    "usualDose": "7.5–25 mg once weekly.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "Usual weekly dose may be used with monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Dose reduction",
        "details": "Consider 50–70% of usual dose; monitor FBC, LFTs and eGFR closely."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Avoid due to risk of severe toxicity (myelosuppression)."
      }
    ],
    "notes": [
      "Ensure folic acid supplementation.",
      "Never take daily — weekly only."
    ]
  },
  {
    "id": "allopurinol-extra",
    "name": "Allopurinol (alternative entry)",
    "searchTerms": ["allopurinol"],
    "className": "Xanthine oxidase inhibitor",
    "tags": ["Gout"],
    "usualDose": "100–300 mg daily, titrated.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR ≥ 60",
        "category": "Standard",
        "details": "May use standard titration."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30–59",
        "category": "Lower start",
        "details": "Start with 50–100 mg daily; titrate to urate."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist only",
        "details": "Use with extreme caution; hypersensitivity risk increased."
      }
    ],
    "notes": [
      "Separate duplicate entry optional – delete if unwanted.",
      "Check HLA-B*5801 in high-risk ethnic groups if available."
    ]
  }
]
